We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Doctor's Choices Influenced by Lab Test Cost

By HospiMedica International staff writers
Posted on 23 Apr 2013
When doctors know what hospitals charge for certain lab tests, they order far fewer of them or look for cheaper alternatives. More...


Investigators discovered that currently hospitals generally do not disclose the price of lab tests to doctors and this contributes to the high cost of health care in the US.

A six-month study looked at the use of 62 diagnostic blood tests frequently ordered for patients at the Johns Hopkins Hospital (Baltimore, MD, USA) Doctors in one group were given the cost of each of the tests while doctors in another group were not provided with that information.

The group of doctors who knew the prices ordered nearly 9% fewer lab tests, which saved more than USD 400,000 over the study period, according to the study appearing April 15, 2013, in the journal JAMA Internal Medicine. There was a 6% increase in the number of tests ordered by the group of doctors who did not know the prices.

"We generally don't make decisions based on what is cost-effective or what is known to be absolutely necessary for our patients, but knowing the cost of things appears to make us more thoughtful about what we think might be best for their health," study leader Dr. Leonard Feldman, an assistant professor of medicine at Johns Hopkins, said in a hospital news release. He added, "There's a lot of waste in medicine because we don't have a sense of the costs of much of what we do."

Feldman said the findings offer "evidence that presenting providers with associated test fees as they order is a simple and unobtrusive way to alter behavior. In the end, we ordered fewer tests, saved money, and saved patients from extra needle sticks without any negative outcomes."

Many of the savings seen in the study were the result of comparison-shopping. For example, it cost USD 15.44 for a comprehensive metabolic panel, a blood test that checks fluid and electrolyte status, kidney and liver function, blood sugar levels, and response to various medications. A basic metabolic panel checks many of the same things but costs USD 3.08.

During the six-month study, the number of comprehensive metabolic panel tests ordered by doctors who knew the price fell by about 8,900, while the number of basic metabolic panels grew by about the same number. That shift alone saved more than USD 27,000 over the study period, the scientists said.

Related Links:

Johns Hopkins Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.